Received Mar 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | IM |
he had chills; he had fever; This non-serious case was reported by a consumer via call center representative and described the occurrence of chills in a 75-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles. On 07-MAR-2025, the patient received the 1st dose of Shingrix (intramuscular). On 07-MAR-2025, less than a day after receiving Shingrix, the patient experienced chills (Verbatim: he had chills) and fever (Verbatim: he had fever). The outcome of the chills and fever were resolved. It was unknown if the reporter considered the chills and fever to be related to Shingrix. It was unknown if the company considered the chills and fever to be related to Shingrix. Additional Information: GSK receipt date: 10-MAR-2025 The patient wife reporting on behalf of her husband. She stated that her husband received his first dose of Shingrix vaccine and experienced chills and a fever. The reporter stated that her husband was better on the day of reporting and was at the gym working out. The reporter reported that her husband had a past medical history of shingles. Reporter declines follow up for her husband or with the primary care physician for her husband. No further information was obtained/provided including what arm the husband had the vaccine administered in. The consumer was unable to locate lot number on material provided from pharmacy. Lot number may not had been provided to consumer.; Sender's Comments: US-GSK-US2025029170:same reporter, female patient
Medical History/Concurrent Conditions: Shingles